A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

NCT06402058 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samyang Biopharmaceuticals Corporation